Search
152 results found for “NS0-521日本語認定対策 😲 NS0-521練習問題 🎃 NS0-521練習問題 🚣 ▷ www.goshiken.com ◁に移動し、【 NS0-521 】を検索して無料でダウンロードしてくださいNS0-521日本語講座”
Carterra awarded 10 Fastest Growing Life Sciences Companies to Watch in 2022
https://carterra-bio.com/news/carterra-awarded-10-fastest-growing-life-sciences-companies-to-watch-in-2022/…combat these diseases. One such obstacle is throughput, as researchers try to screen and characterize large libraries of antibody candidates as quickly as possible during the early screening process for…
Fc-Gamma Receptor Binding
https://carterra-bio.com/applications/fc-gamma-receptor-binding/…measured on the LSAXT as compared to the Biacore 8K. Figure 2. Significant reduction in resources required to perform FcγR characterization on the LSAXT as compared with the Biacore 8K….
Screening for Allosteric Competition Using High Throughput SPR
https://carterra-bio.com/resources/allosteric-competition-application-note/…action (MOA) when competition is observed. A screening approach that can more readily distinguish orthosteric competition from indirect (allosteric) competition presents key opportunities towards detecting therapeutically unique mAbs. Additionally, identifying…
Restricted Epitope Specificity Determined by Variable Region Germline Segment Pairing in Rodent Antibody Repertoires – February 10, 2020
https://carterra-bio.com/resources/restricted-epitope-specificity-determined-by-variable-region-germline-segment-pairing-in-rodent-antibody-repertoires-february-10-2020/…chain third complementarity-determining region (CDR H3), a critical specificity determinant. Whether these V germline segment-restricted responses reflect a general epitope specificity restriction of antibodies with shared VH/VL pairing is not…
Scientist-to-Scientist Series: High-throughput binding characterization assays and antibody discovery
https://carterra-bio.com/resources/carterras-scientist-to-scientist-series-alyssa-hughes-and-mike-brown-at-adimab/In the fourth edition of our information-packed Scientist-to-Scientist Series, Alyssa Hughes, Applications Scientist at Carterra, talks to Mike Brown, Senior Scientist at Adimab. https://www.youtube.com/watch?v=9iAqJGLNYfs Posted by Alyssa Hughes View Transcript…
Immunity Monitoring of COVID-19 Patients Using a SARS-CoV-2 Label-free Assay
https://carterra-bio.com/news/carterra-announces-successful-immunity-monitoring-of-covid-19-patients-using-a-sars-cov-2-label-free-assay/…give researchers the most comprehensive insight into serum immune reactivity, specificity, and epitope binding. “The pandemic has forced the scientific community to find ways to discover and develop therapeutics and…
Dragonfly Therapeutics Presents Advances in Antibody Discovery for Bispecific Therapeutics – June 11, 2020
https://carterra-bio.com/resources/dragonfly-therapeutics-presents-advances-in-antibody-discovery-for-bispecific-therapeutics/…quite nicely. So upon a certain combination of receptors being ligated on the NK cell, and missing inhibitory signals, this NK cell packed with granules of these perforins and granzymes…
Carterra CEO, Josh Eckman, Recognized as a Rising Star by the David Eccles School of Business
https://carterra-bio.com/news/carterra-ceo-josh-eckman-recognized-as-a-rising-star-by-the-david-eccles-school-of-business/…times faster than existing platforms, compressing months of work into days and addressing a significant bottleneck in drug discovery. Under Josh’s leadership, the Company recently raised $10M from Telegraph Hill…
Therapeutic Areas
https://carterra-bio.com/applications/therapeutic-areas/Therapeutic Areas in Drug Discovery & Clinical Research…
Product Overview
https://carterra-bio.com/product-overview/HT-SPR technology with options Our platforms can transform your label-free characterization workflow allowing screening and characterization, for both large and small molecules, in a single step. Check them out! LSA…